The quintessence of immunogenicity reporting for biotherapeutics

Nat Biotechnol. 2015 Apr;33(4):334-6. doi: 10.1038/nbt.3181.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Products / adverse effects*
  • Biological Products / immunology*
  • Biopharmaceutics / methods*
  • Disclosure*
  • Drug Labeling / methods
  • Humans
  • Immune System Diseases / chemically induced*
  • Immune System Diseases / immunology*

Substances

  • Biological Products